Company_Context
Basic Materials
Pharmaceutical Preparations
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Signal_Window
Headline metrics use exact calendar-day windows.
29 directional transactions in 365D
Code P purchases and code S sales are measured from 2025.08.29 — 2026.08.28.
-$155.4M
Open-market buys minus sales2026.08.17
Latest available filing22
Reporting entities in windowMORIKIS JOHN G
$257.7KDuato Joaquin
$66.8MAnalysis of eligible SEC Form 4 activity for JNJ indicates a bearish 365-day signal. The selected window contains transactions from 22 distinct reporting insiders, with aggregate nominal activity of $283.12M.
Open-market purchases minus open-market sales produce a negative net flow of $155.41M. Open-market executions represent the majority of measured nominal activity in this window, making the directional flow more representative of voluntary trading activity.
MORIKIS JOHN G recorded the largest aggregate purchase volume, while Duato Joaquin recorded the largest aggregate sale volume. Form 4 activity provides useful ownership context, but it should not be treated as a standalone prediction of future price performance.
Enriched_Research_Context
These indicators use normalized SEC roles, issuer metadata, cluster detection and post-filing market prices already calculated by the data pipeline.
Basic Materials
Pharmaceutical Preparations
0
Clustered open-market purchase records in the recent filing sample.
Recent_Filing_History
This table shows recent filing history and is not restricted by the selected 365D headline signal window.
The selected 365-day window contains 22 distinct reporting insiders with eligible transactions for JNJ. This count changes when a different signal window is selected.
Open-market selling volume ($155.66M) currently exceeds buying volume ($0.26M), indicating net liquidation by insiders.
During the last 365 calendar days, MORIKIS JOHN G (Director) recorded the largest aggregate open-market purchase volume. Total insider buying in the window is $0.26M.
Wengel Kathryn E
OPEN_MARKET_SALEOther Officer · 2026.06.11
30D
+8.2%
90D
PENDING
180D
PENDING
Performance uses the latest matured open-market record in this sample. It describes subsequent market movement and does not imply that the filing caused the price change.